Click here for Ebola Virus information

Decision paves way for WHO to assess malaria vaccine

WHO Logo2PATH’s Malaria Vaccine Initiative (MVI) says it welcomes the positive scientific opinion adopted by European regulatory authorities for GlaxoSmithKline (GSK) candidate malaria vaccine Mosquirix™ (RTS,S) for prevention of malaria in young children aged 6 weeks to 17 months in sub-Saharan Africa. A statement copied to GNA said, PATH was joined in its response by leading African researchers from sites that conducted the pivotal Phase three efficacy and safety trial. PATH is the leader in global health innovation. An international non-profit organization, we save lives and improve health, especially among women and children The opinion is being adopted by the Committee for Medicinal Products » Read More

Aug 1
Health Insurance Authority urges review of Scheme
Include Hygiene in post-2015 Sustainable Development Goals - NGO
Safe and adequate breast feeding promotes healthy life
Jul 31
Students Benefit from hearing screening exercises
Psychiatric nurses to strike over unpaid salary
Chief of Staff to meet GHOSPA today over impending strike
Doctors must ‘persevere’ and use dialogue – Labour analyst
Doctors on strike: 80-year-old injured woman battles for life
National Health Insurance Authority to register prisoners
Hepatitis programme launched
90 babies die daily
Airtel Ghana donates to Adansi health facility
Health professionals tasked to respect dignity of patients
Societe Generale supports Ghana Heart Foundation
NHIS freely registered 1.5m poor people in 2014
 
» More Health News